Recombinant Proteins Fall Special Offers - Full-Length Proteins

Full-length recombinant proteins offer significant advantages in research, diagnostics, and therapeutic development by retaining the entire amino acid sequence of the native protein, ensuring full structural integrity and biological activity. They produce more accurate and predictive results in preclinical studies, especially in drug discovery, by mimicking native conditions. In vaccine development, full-length recombinant proteins can present a more comprehensive antigenicity due to the exposure of multiple epitopes to generate a better immune response. In addition, full-length proteins allow for necessary post-translational modifications, such as glycosylation, phosphorylation, or ubiquitination. These modifications are often critical for the activity, stability, and interactions of the protein and can affect the results of biochemical and cellular assays.

In functional assays, full-length proteins allow for the study of interactions and functions that may be missed in truncated versions, resulting in more comprehensive data. For studies involving protein structure and function, full-length proteins provide a complete picture of how different domains interact within the protein and how these interactions affect its function. This is essential for understanding mechanisms of action, identifying drug targets, and designing protein variants with enhanced properties.

Beta LifeScience is launching a special promotion for in-stock full-length recombinant proteins with high purity, high compatibility, high stability, low endotoxin, rich vectors, diverse species, and multiple expression systems. Work with us to unleash the true power of full-length proteins and take your research to the next level.